应用Dot—ELISA检测PVX,PVY和PVS

以ＮＣＭ为固相载体、应用间接ＥＬＩＳＡ法测定了纯化的ＰＶＸ、ＰＶＹ和ＰＶＳ;对接种的烟草,马铃薯块茎的芽、休眠块茎顶端的稀释度ＰＶＸ分别为：１／２０４８０－１／８１９２０、１／５１２０;ＰＶＹ分别为１／８１９２０、１／２０４８０和１／５１２０;ＰＶＳ分别为１／８１９２０－１／３２７６８０、１／２０４８０－１／８１９２０和１／５１２０－１／２０４８０,和Ｃｏｃｋｔａｉｌ－ＥＬＩＳＡ相关,检测ＰＶＸ和     

病毒诱导的PVX cp转基因沉默及其DNA甲基化

利用PCR方法获得了马铃薯X病毒(PVX)外壳蛋白(CP)基因(cp),并将其构建到植物表达载体中,利用农杆菌介导的叶盘法转化烟草(Nicotiana tabacum L.)。Northern杂交及Run on实验表明有3株转基因烟草发生了转录后基因沉默。发生沉默的cp基因的甲基化分析结果表明,发生转录后基因沉默的cp基因发生了不同程度的甲基化,说明DNA甲基化并没有完全抑制cp基因的转录。利用PVX病毒对外壳蛋白正常表达的转基因烟草进行接毒,Northern杂交检测结果表明,病毒诱导cp发生了基因沉默。进一步的Run on结果表明,转基因烟草中cp基因在沉默前后转录速率并没有发生变化,说明病毒诱导的沉默是一种转录后沉默。对cp基因沉默前后的甲基化分析表明,病毒的侵染导致了cp基因甲基化程度的增加。     

病毒诱导的PVX cp转基因沉默及其DNA甲基化

利用PCR方法获得了马铃薯X病毒(PVX)外壳蛋白(CP)基因(cp),并将其构建到植物表达载体中,利用农杆菌介导的叶盘法转化烟草(Nicotiana tabacum L.).Northern杂交及Run on实验表明有3株转基因烟草发生了转录后基因沉默.发生沉默的cp基因的甲基化分析结果表明,发生转录后基因沉默的cp基因发生了不同程度的甲基化,说明DNA甲基化并没有完全抑制cp基因的转录.利用PVX病毒对外壳蛋白正常表达的转基因烟草进行接毒,Northern杂交检测结果表明,病毒诱导cp发生了基因沉默.进一步的Run on结果表明,转基因烟草中cp基因在沉默前后转录速率并没有发生变化,说明病毒诱导的沉默是一种转录后沉默.对cp基因沉默前后的甲基化分析表明,病毒的侵染导致了cp基因甲基化程度的增加.     

利用PCR对PVX外壳蛋白基因进行同义密码子修饰

利用聚合酶链式反应 (PolymeraseChainReaction ,PCR)与限制性内切酶相结合的方法 ,设计 4条含有限制性酶切位点和相应突变的引物。以马铃薯X病毒 (PotatoVirusX ,PVX)外壳蛋白cp基因为模板 ,扩增出相应的片段 ,相应酶切后通过三片段连接构建到克隆载体pBlueKS( / - )上。随机挑选重组子测序表明 ,利用三片段拼接成功地在PVX外壳蛋白基因的不同部位产生了突变。实验结果说明利用三片段接可以大大提高筛选得到突变子的效率 ,从而节省人力、物力和时间。     

华盛顿大学等开发抗CMV、AIMV、PVX的重组植物

美国华盛顿大学(密苏里州圣路易丝)生物学部的Roger.N.Beachy与孟山都公司共同导入植物病毒的外壳蛋白基因,分别成功地培育出抗病毒的植物。该小组已用这种方法培育出抗烟草花叶病毒(TMV)的烟草、番茄。其中番茄已开始了野外试验。这次把应用范围扩大到TMV以外,所以这种方法应用范围很广,而且实验证明能应用于抗病毒,病害的     

马铃薯Y病毒蚜传辅助成分介导PVX/PVY协生作用

构建了马铃薯Y病毒中国株系（PVY－C）蚜传辅助成分（HC－Pro）基因的正义、反义和缺失三种植物表达载体,通过农杆菌介导法转化烟草品种NC89。Southern blot分析表明,HC－Pro基因及其突变体已经整合到烟草染色体中,Western blot分析证明,正义HC－Pro基因及其缺失突变体在转基因烟草中有表达产物,攻毒试验结果表明,转正义,HC－Pro基因及其缺失突变体不仅能够提高T1转基因烟草中PVY－C的病毒积累和致病,而且对异源病毒PVX具有同样的作用,而转反义HC－Pro基因烟草对PVY－C和PVX的致病性无影响,因此,PVY－C HC－Pro基因介导PVX／PVY的协作作用。     

大麦黄矮病毒运动蛋白核定位信号对PVX病毒运动的影响

应用马铃薯X病毒(PVX)载体研究大麦黄矮病毒运动蛋白(BYDV-MP)核定位信号对PVX病毒运动的影响。我们将BYDV-MP克隆到PVX改造载体pGR107中,同时用GFP作为指示蛋白,研究BYDV-MP对异源病毒PVX系统运动的影响。侵染烟草发现BYDV-MP能够在PVX载体中表达并能加强病毒的系统侵染;将PVX编码系统运动蛋白25kD基因进行缺失突变,重复上述试验发现BYDV-MP能够补偿PVX系统运动;将BYDV-MP的N端的第五、六位氨基酸和第七位氨基酸进行替换突变,侵染烟草发现BYDV-MP的N端的第五、六位氨基酸突变不能完全抑制PVX系统运动,但是可以延迟并减弱PVX系统运动;BYDV-MP的N端的第七位氨基酸突变能够完全抑制PVX系统运动。     

微生物发酵生产十一烷1，1 1二羧酸的研究

从热带假丝酵母(Candiada tropicalis)T25—14经过紫外线和亚硝酸的多次诱变,获得4株产十一烷l,11二羧酸(DC₁₃)较多的突变株,其中最优的NP-159株以20％(V／V)正十三烷(nC₁₃)为碳源摇瓶发酵4天,DC₁₃达80g／L左右。在16L罐上,以30％(V／V)nC₁₃发酵6天,DC₁₃高达139g／L,回收残烃后,对nC₁₃的转化率为80％以上。后处理收率为78．9％,DC₁₃的纯度为95．3％。     

Human kidney anion exchanger 1 interacts with adaptor-related protein complex 1 μ1A (AP-1 mu1A)

Kidney anion exchanger 1 (kAE1) mediates chloride (Cl⁻) and bicarbonate (HCO₃⁻) exchange at the basolateral membrane of kidney α-intercalated cells. Impaired trafficking of kAE1 leads to defect of the Cl⁻/HCO₃⁻ exchange at the basolateral membrane and failure of proton (H⁺) secretion at the apical membrane, causing a kidney disease - distal renal tubular acidosis (dRTA). To gain a better insight into kAE1 trafficking, we searched for proteins physically interacting with the C-terminal region of kAE1 (Ct-kAE1), which contains motifs crucial for intracellular trafficking, by a yeast two-hybrid (Y2H) system. An adaptor-related protein complex 1 μ1A (AP-1 mu1A) subunit was found to interact with Ct-kAE1. The interaction between either Ct-kAE1 or full-length kAE1 and AP-1 mu1A were confirmed in human embryonic kidney (HEK) 293T by co-immunoprecipitation, affinity co-purification, co-localization, yellow fluorescent protein (YFP)-based protein fragment complementation assay (PCA) and GST pull-down assay. The interacting site for AP-1 mu1A on Ct-kAE1 was found to be Y904DEV907, a subset of YXXØ motif. Interestingly, suppression of endogenous AP-1 mu1A in HEK 293T by small interfering RNA (siRNA) decreased membrane localization of kAE1 and increased its intracellular accumulation, suggesting for the first time that AP-1 mu1A is involved in the kAE1 trafficking of kidney α-intercalated cells.     

Niemann–Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter

Niemann–Pick C1 Like 1 (NPC1L1) has been identified and characterized as an essential protein in the intestinal cholesterol absorption process. NPC1L1 localizes to the brush border membrane of absorptive enterocytes in the small intestine. Intestinal expression of NPC1L1 is down regulated by diets containing high levels of cholesterol. While otherwise phenotypically normal, Npc1l1 null mice exhibit a significant reduction in the intestinal uptake and absorption of cholesterol and phytosterols. Characterization of the NPC1L1 pathway revealed that cholesterol absorption inhibitor ezetimibe specifically binds to an extracellular loop of NPC1L1 and inhibits its sterol transport function. Npc1l1 null mice are resistant to diet-induced hypercholesterolemia, and when crossed with apo E null mice, are completely resistant to the development of atherosclerosis. Intestinal gene expression studies in Npc1l1 null mice indicated that no exogenous cholesterol was entering enterocytes lacking NPC1L1, which resulted in an upregulation of intestinal and hepatic LDL receptor and cholesterol biosynthetic gene expression. Polymorphisms in the human NPC1L1 gene have been found to influence cholesterol absorption and plasma low density lipoprotein levels. Therefore, NPC1L1 is a critical intestinal sterol uptake transporter which influences whole body cholesterol homeostasis.     

细胞色素P450 1A1和1B1靶向抗肿瘤前药研究进展

细胞色素P450（CYP）能催化各种内源性及外源性化合物的代谢,与多种肿瘤发生有关。其中CYP1A1参与多种前致癌物和致突变物的代谢活化,CYP1B1被认为在许多人癌细胞中特异性表达,参与药物的氧化代谢和前药的活化。CYP1A1和181已成为靶向抗肿瘤前药研究的新靶点。相继有大量相关研究报道,本文就近年来文献报道的CYP1A1和1B1靶向抗肿瘤前药研究进展。     

Tbf1 or not Tbf1?

In this issue of Molecular Cell, Hogues et al. (2008) demonstrate a wholesale shift in the key regulatory protein involved in ribosomal protein (RP) synthesis during the evolution of S. cerevisiae and, en passant, raise interesting questions about the relationship between RP genes and telomeres.     

CYP1B1基因与青光眼

遗传性青光眼包括两种主要的类型,原发性开角型青光眼(primary open angle glaucoma,POAG)和原发性先天型青光眼(primary congenital glaucoma,PCG).眼前节发育不良(anterior segment dysgenesis,ASD)是眼发育异常的遗传异质性病,与增长的眼内压和青光眼有关,包括Peter's异常、Rieger's异常、无虹膜和虹膜发育不全.CYPIB1基因是PCG的致病基因,也有少数报道是POAG的修饰基因,或是POAG和ASD的致病基因.本文就CYP1B1基因突变与遗传性青光眼和ASD发育不全的关系及其遗传特点作一综述.     

问题解答1

问 :蛋白质、核酸都是通过缩聚反应形成的吗 ?答 :由于人们对教材内容机械引入或对教材语意曲解 ,因而众多的复习资料无论在介绍蛋白质、核酸的结构还是生命起源时都人为地强调氨基酸“缩合”形成蛋白质、核苷酸“聚合”形成核酸。“缩合”与“聚合”似乎成了风马牛不相及的两个概念 ,更谈不上去探索其有机联系了。缩合源于生物化学中蛋白质 (或肽 )的形成 ,它可以指两个或多个氨基酸形成肽时脱去一个或多个水分子的反应。正由于它脱去小分子物质 ,而有别于加成反应 ,同时它发生在有机的小分子之间 ,且反应结果并没有形成不饱合键而不同于消…     

沉默DEPDC1抑制鼻咽癌细胞HNE-1和CNE-1侵袭迁移

DEPDC1(DEP domain containing 1)是一个新的肿瘤相关基因,在多种恶性肿瘤的发生发展进程中起着重要作用。我们前期工作中在鼻咽癌细胞内沉默了DEPDC1的表达,发现抑制细胞增殖并诱发细胞凋亡。本研究旨在探讨沉默DEPDC1表达后,对鼻咽癌细胞HNE-1和CNE-1侵袭迁移能力的影响及其分子机制。结果显示,siRNA介导DEPDC1表达沉默后,细胞侧向运动能力、侵袭及迁移能力显著降低。qRT-PCR及Western印迹检测发现DEPDC1沉默导致EMT上游关键转录因子Twist1及间质细胞标志分子Vimentin表达显著下调。这些研究表明,鼻咽癌细胞中DEPDC1通过调节Twist1等EMT关键分子的表达在细胞侵袭转移过程中起关键作用。推测DEPDC1在鼻咽癌中高表达可能对于促进其侵袭转移具有重要作用,进而促进肿瘤发生发展,但具体分子机制仍有待更深入研究。     

Mutators in SACCHAROMYCES CEREVISIAE: MUT1–1, MUT1–2 and MUT2–1

The purpose of this study was to characterize two mutator stocks of yeast which were induced and selected on the basis of high spontaneous reversion rates of the suppressible "ochre" nonsense allele lys1-1. In the mutator stock VA-3, a single mutation, designated mut1-1, is responsible for the increase in the reversion rate of the ochre alleles lys1-1 and arg4-17. In stock VA-105, there are two separate mutator mutations. Tetrad analysis data showed these two loci are loosely linked. Based on complementation data, one of these mutations is at the same locus as mut1-1 and designated mut1-2. The second mutator of stock VA-105 was designated mut2-1. All three mutators are recessive. Both mut1-1 and mut1-2 give a high mutation rate for ochre nonsense suppressor (SUP) loci, but not for the ochre nonsense alleles. On the contrary, the mutation rates of the ochre alleles are greatly reduced. With the mutant mut2-1 there were mutations at both the lys1-1 site and its suppressors; mut2-1 is as effective as mut1-2 but not as effective as mut1-1 in inducing reversions of a missense mutant, his1-7. Neither mut1-1, mut1-2 nor mut2-1 were effective in inducing reversions of a putative frameshift mutation, hom3-10, or in inducing forward mutations to canavanine resistance.